4D Molecular Therapeutics, Inc. (FDMT) Advances Gene Therapy

4D Molecular Therapeutics, Inc. (FDMT) is a clinical-stage biopharmaceutical company developing next-generation gene therapies using its proprietary AAV-based vector platform. The company’s pipeline targets genetic eye diseases, rare conditions, and oncology, aiming to deliver precision treatments where no effective options currently exist. 4DMT’s growth is driven by advancing clinical trials, partnerships with major biotech firms, and the growing global demand for transformative genetic medicines.

On the chart, a confirmation bar with rising volume highlights bullish sentiment. The price has entered the momentum zone after breaking above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci mark using the Fibonacci snap tool, helping traders secure profits while leaving room for continued upside potential.